CXCL13 and inflammatory bowel disease: A higher level of serum CXCL13 was correlated with inflammatory responses in IBD patients (including UC and CD) and DSS-induced mice, and colitis was alleviated in CXCL13-deficient mice or those administrated anti-CXCL13 antibodies [36].